Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Pyrukynd
.
Show all posts
Showing posts with label
Pyrukynd
.
Show all posts
Thursday, March 3, 2022
FDA Approves Pyrukynd (mitapivat) as First Disease-Modifying Therapy for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency
›
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering therapies for genetically defined diseas...
›
Home
View web version
